Chemomab Therapeutics Ltd.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-3.7M | $-3.8M | $75.0K | — |
| FY2017 | $-8.5M | $-8.5M | $34.0K | $700.0K |
| FY2018 | $-14.2M | $-14.4M | $213.0K | $1.9M |
| FY2019 | $-16.5M | $-16.6M | $95.0K | $1.2M |
| FY2020 | $-5.2M | $-5.3M | $38.0K | $130.0K |
| FY2021 | $-12.4M | $-12.6M | $239.0K | $2.0M |
| FY2022 | $-20.4M | $-20.4M | $68.0K | $3.2M |
| FY2023 | $-23.6M | $-23.6M | $3.0K | $1.5M |
| FY2024 | $-15.4M | $-15.4M | $0 | $617.0K |
| FY2025 | $-11.1M | $-11.1M | $3.0K | $623.0K |